Advances Shaping the Future of the Neuroblastoma Market
The Neuroblastoma Market is on the precipice of significant growth, with the market size projected to reach approximately 559.08 million USD by 2035. This surge reflects an impressive compound annual growth rate (CAGR) of 3.4%, showcasing the increasing demand for effective treatments for this aggressive pediatric cancer. As both the incidence of neuroblastoma rises and the focus on pediatric...
0 Comments 0 Shares 55 Views 0 Reviews